Virtu KCG Holdings’s Integra LifeSciences IART Stock Holding History

Virtu KCG Holdings’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$202K	Sell	3,714 -23,970	-87%	-$1.14M	0.01%	2152
2017 Q1	$1.17M	Buy	27,684 +8,132	+42%	+$347K	0.03%	595
2016 Q4	$839K	Sell	19,552 -26,604	-58%	-$1.08M	0.02%	927
2016 Q3	$1.91M	Buy	+46,156	New	+$1.93M	0.05%	330
2015 Q3	–	Sell	-15,454	Closed	-$426K	–	3539
2015 Q2	$426K	Buy	+15,454	New	+$412K	0.01%	1634

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu KCG Holdings's IART Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Integra LifeSciences (IART) stake by 87% in Q2 2017, selling an estimated $1.14M and leaving 3,714 shares worth $202K. The position accounts for 0.01% of the portfolio, ranked #2152.

Virtu KCG Holdings first reported a position in IART in Q2 2015 and has held it in 5 quarters since. The position peaked at $1.91M in Q3 2016. 224 funds tracked by Wall St. Rank hold IART as of Q2 2017.

Virtu KCG Holdings held 3,714 shares of Integra LifeSciences worth $202K as of Q2 2017.
Virtu KCG Holdings sold 23,970 Integra LifeSciences shares in Q2 2017, an estimated $1.14M.
Integra LifeSciences made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2152 holding.
Virtu KCG Holdings first reported a position in Integra LifeSciences in Q2 2015 and has held it in 5 quarters since.
Virtu KCG Holdings's Integra LifeSciences position peaked at $1.91M in Q3 2016.
224 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.